ArticleSubstance abuse treatment, prevention, and policy2013
Subjective stressors in school and their relation to neuroenhancement: a behavioral perspective on students' everyday life "doping".
Article in Substance abuse treatment, prevention, and policy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.
- Stimulant abuse as a coping strategy-Forensic and criminal consequences of stimulant abuse for neuroenhancement.Frontiers in public health · 2022Pooled it
- From Doping Intentions to Life Aspirations: A Goal Systems Perspective of Performance Enhancement in Sport.Sports (Basel, Switzerland) · 2026Article
- A Preliminary Investigation of a Conceptual Framework of Performance Enhancement Across Different Life Domains.Sports (Basel, Switzerland) · 2025Article
- Adapting Ourselves, Instead of the Environment: An Inquiry into Human Enhancement for Function and Beyond.Integrative psychological & behavioral science · 2024Article
- The Role of Different Behavioral and Psychosocial Factors in the Context of Pharmaceutical Cognitive Enhancers' Misuse.Healthcare (Basel, Switzerland) · 2022Article
- Potential risk groups and psychological, psychosocial, and health behavioral predictors of pharmacological neuroenhancement among university students in Germany.Scientific reports · 2022Article
- Non-pharmacological factors that determine drug use and addiction.Neuroscience and biobehavioral reviews · 2020Review
- Professionals' attitudes towards the use of cognitive enhancers in academic settings.PloS one · 2020Article
- Pharmacological neuroenhancement and the ability to recover from stress - a representative cross-sectional survey among the German population.Substance abuse treatment, prevention, and policy · 2018Article
- Prevalence Estimates for Pharmacological Neuroenhancement in Austrian University Students: Its Relation to Health-Related Risk Attitude and the Framing Effect of Caffeine Tablets.Frontiers in pharmacology · 2018Article
- Drugs As Instruments: Describing and Testing a Behavioral Approach to the Study of Neuroenhancement.Frontiers in psychology · 2016Article
- Using Caffeine Pills for Performance Enhancement. An Experimental Study on University Students' Willingness and Their Intention to Try Neuroenhancements.Frontiers in psychology · 2016Article
- Why is Cognitive Enhancement Deemed Unacceptable? The Role of Fairness, Deservingness, and Hollow Achievements.Frontiers in psychology · 2016Article
- "It Was Me on a Good Day": Exploring the Smart Drug Use Phenomenon in England.Frontiers in psychology · 2016Article
- Editorial: Using Substances to Enhance Performance: A Psychology of Neuroenhancement.Frontiers in psychology · 2016Article
- A survey of substance use for cognitive enhancement by university students in the Netherlands.Frontiers in systems neuroscience · 2015Article
- Associations Between the Big Five Personality Traits and the Non-Medical Use of Prescription Drugs for Cognitive Enhancement.Frontiers in psychology · 2015Article
- Cerebral Correlates of Automatic Associations Towards Performance Enhancing Substances.Frontiers in psychology · 2015Article
- The Complexity of Neuroenhancement and the Adoption of a Social Cognitive Perspective.Frontiers in psychology · 2015Article
- Neuroenhancement and the strength model of self-control.Frontiers in psychology · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe use of psychoactive substances to neuroenhance cognitive performance is prevalent. Neuroenhancement (NE) in everyday life and doping in sport might rest on similar attitudinal representations, and both behaviors can be theoretically modeled by comparable means-to-end relations (substance-performance). A behavioral (not substance-based) definition of NE is proposed, with assumed functionality as its core component. It is empirically tested whether different NE variants (lifestyle drug, prescription drug, and illicit substance) can be regressed to school stressors.
findingsParticipants were 519 students (25.8 ± 8.4 years old, 73.1% female). Logistic regressions indicate that a modified doping attitude scale can predict all three NE variants. Multiple NE substance abuse was frequent. Overwhelming demands in school were associated with lifestyle and prescription drug NE.
conclusionsResearchers should be sensitive for probable structural similarities between enhancement in everyday life and sport and systematically explore where findings from one domain can be adapted for the other. Policy makers should be aware that students might misperceive NE as an acceptable means of coping with stress in school, and help to form societal sensitivity for the topic of NE among our younger ones in general.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.